MediPal Holdings Corporation (TYO:7459)
Japan
· Delayed Price · Currency is JPY 2,267.50
+2.00 (0.09%)
May 27, 2025, 3:30 PM JST
MediPal Holdings Revenue
In the fiscal year ending March 31, 2025, MediPal Holdings had annual revenue of 3.67T JPY with 3.16% growth. MediPal Holdings had revenue of 864.16B in the quarter ending March 31, 2025, with 2.41% growth.
Revenue
3,671.33B
Revenue Growth
+3.16%
P/S Ratio
0.13
Revenue / Employee
280.79M
Employees
13,075
Market Cap
471.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3,671.33B | 112.60B | 3.16% |
| Mar 31, 2024 | 3,558.73B | 198.72B | 5.91% |
| Mar 31, 2023 | 3,360.01B | 69.09B | 2.10% |
| Mar 31, 2022 | 3,290.92B | 79.80B | 2.48% |
| Mar 31, 2021 | 3,211.13B | -41.95B | -1.29% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |